As a part of Singclean global expansion strategy of Singfiller brand we proudly announce to launch Singfiller on the Polish market from October 2017.
This International Congress of Aesthetic Medicine and Anti-Aging is among largest meetings of physicians and key experts in the aesthetic medicine industry and exhibitors of products applied in aesthetic medicine.
The three-day event, organized annually, gave a great opportunity to meet outstanding scientists and practitioners from around the world working for the development of this branch of medicine. This is the greatest such congress in Central Europe.
As part of the congress, 77 exhibitors representing domestic and foreign companies presented their products. One of them, Medical Expert S.A. - our exclusive distributor in Poland, was pleased to present the Singfiller products for countrywide distribution as a part of the Singclean expansion to the European market.
We invite all Polish customers to try our Singfiller products!
For enquiries please contact
Our authorised Distributor
Medical Expert S.A.
biuro@medicalexpert.com.pl
and visit local product website
-
singclean | 2017-10-25Singclean Draws Major Attention at ESCRS 2025 with Advanced Viscoelastic Solution for Ophthalmic SurgeryCOPENHAGEN, DENMARK – Hangzhou Singclean Medical Products Co., Ltd. made a strong impression at the 45th ESCRS Congress (European Society of Cataract and Refractive Surgeons), held September 12–16, 2025, at the Bella Center in Copenhagen. Recognized globally for its high professional standards and influence in ophthalmology, the congress gathered leading industry manufacturers, surgeons, and specialists from around the world.
-
singclean | 2017-10-25Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.
-
singclean | 2017-10-25Singclean to Showcase Innovative Medical Solutions at Key International Exhibitions in Bangkok and Copenhagen